Cargando…

Mitochondrial oxidative phosphorylation is dispensable for survival of CD34(+) chronic myeloid leukemia stem and progenitor cells

Chronic myeloid leukemia (CML) are initiated and sustained by self-renewing malignant CD34(+) stem cells. Extensive efforts have been made to reveal the metabolic signature of the leukemia stem/progenitor cells in genomic, transcriptomic, and metabolomic studies. However, very little proteomic inves...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yan, Jin-Song, Yang, Meng-Ying, Zhang, Xue-Hong, Luo, Chen-Hui, Du, Cheng-Kan, Jiang, Yue, Dong, Xuan-Jia, Wang, Zhang-Man, Yang, Li-Xue, Li, Yi-Dong, Xia, Li, Lu, Ying
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9021200/ https://www.ncbi.nlm.nih.gov/pubmed/35444236 http://dx.doi.org/10.1038/s41419-022-04842-5

Ejemplares similares

Integration of CD34(+)CD117(dim) population signature improves the prognosis prediction of acute myeloid leukemia
por: Li, Xue-Ping, et al.
Publicado: (2022)

Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients
por: Ricciardi, Maria Rosaria, et al.
Publicado: (2018)

Isolation of Murine Myeloid Progenitor Populations by CD34/CD150 Surface Markers
por: Olender, Leonid, et al.
Publicado: (2022)

Good manufacturing practice production of CD34(+) progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia
por: de Jonge, P. K. J. D., et al.
Publicado: (2023)

Subclones of bone marrow CD34(+) cells in acute myeloid leukemia at diagnosis confer responses of patients to induction chemotherapy
por: Jia, Ruinan, et al.
Publicado: (2022)

Phenotyping and Target Expression Profiling of CD34(+)/CD38(−) and CD34(+)/CD38(+) Stem- and Progenitor cells in Acute Lymphoblastic Leukemia
por: Blatt, Katharina, et al.
Publicado: (2018)

The number of CD34+CD38+CD117+HLA-DR+CD13+CD33+ cells indicates post-chemotherapy hematopoietic recovery in patients with acute myeloid leukemia
por: Gu, Runxia, et al.
Publicado: (2017)

Effect of platelet-activating factor on the growth of human erythroid and myeloid CD34+ progenitors.
por: Dupuis, F, et al.
Publicado: (1998)

Pilot Study on Mass Spectrometry–Based Analysis of the Proteome of CD34(+)CD123(+) Progenitor Cells for the Identification of Potential Targets for Immunotherapy in Acute Myeloid Leukemia
por: Schmidt, Johannes R., et al.
Publicado: (2018)

Isolation and Characterization of CD34+ Blast-Derived Exosomes in Acute Myeloid Leukemia
por: Hong, Chang Sook, et al.
Publicado: (2014)

Curcumin reduces expression of Bcl-2, leading to apoptosis in daunorubicin-insensitive CD34(+ )acute myeloid leukemia cell lines and primary sorted CD34(+ )acute myeloid leukemia cells
por: Rao, Jia, et al.
Publicado: (2011)

FISH(+)CD34(+)CD38(-) cells detected in newly diagnosed acute myeloid leukemia patients can predict the clinical outcome
por: Wang, Libing, et al.
Publicado: (2013)

In vitro effects of imatinib on CD34(+) cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase
por: MENG, FANKAI, et al.
Publicado: (2014)

HIV-1 infection depletes human CD34(+)CD38(-) hematopoietic progenitor cells via pDC-dependent mechanisms
por: Li, Guangming, et al.
Publicado: (2017)

High frequency of CD34+CD38-/low immature leukemia cells is correlated with unfavorable prognosis in acute myeloid leukemia
por: Plesa, Adriana, et al.
Publicado: (2017)

Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
por: Ding, Yahui, et al.
Publicado: (2016)

Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis
por: Yu, Yan, et al.
Publicado: (2021)

CD34+/CD38- Stem Cell Burden Could Predict Chronic Myeloid Leukemia Patients’ Outcome
por: Fathy El-Metwaly, Noura, et al.
Publicado: (2021)

CD13 is dispensable for normal hematopoiesis and myeloid cell functions in the mouse
por: Winnicka, Beata, et al.
Publicado: (2010)

Adipocytokines and CD34(+) Progenitor Cells in Alzheimer's Disease
por: Bigalke, Boris, et al.
Publicado: (2011)

Correction to: Alantolactone selectively ablates acute myeloid leukemia stem and progenitor cells
por: Ding, Yahui, et al.
Publicado: (2021)

Zinc finger and BTB domain-containing protein 46 is essential for survival and proliferation of acute myeloid leukemia cell line but dispensable for normal hematopoiesis
por: Liu, Yuan-Yuan, et al.
Publicado: (2020)

TREM2 acts as a receptor for IL-34 to suppress acute myeloid leukemia in mice
por: Xie, Xiaoling, et al.
Publicado: (2023)

CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia
por: Liu, Yongliang, et al.
Publicado: (2021)

CD45(dim)CD34(+)CD38(−)CD133(+) cells have the potential as leukemic stem cells in acute myeloid leukemia
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

TWIST-1 promotes cell growth, drug resistance and progenitor clonogenic capacities in myeloid leukemia and is a novel poor prognostic factor in acute myeloid leukemia
por: Wang, Nan, et al.
Publicado: (2015)

Selective activation of STAT3 and STAT5 dictates the fate of myeloid progenitor cells
por: Zhang, Meichao, et al.
Publicado: (2023)

CD1d levels in peripheral blood of patients with acute myeloid leukemia and acute lymphoblastic leukemia
por: GUO, WENJIAN, et al.
Publicado: (2014)

CD34 and CD38 are prognostic biomarkers for acute B lymphoblastic leukemia
por: Jiang, Zhiwu, et al.
Publicado: (2016)

Precision therapy for acute myeloid leukemia
por: Yang, Xue, et al.
Publicado: (2018)

Notch2 inhibits proliferation of chronic myeloid leukemia cells
por: YANG, ZESONG, et al.
Publicado: (2013)

Mobilization of CD34(+)-Progenitor Cells in Patients with Severe Trauma
por: Ritz, Ulrike, et al.
Publicado: (2014)

Osteoprotegerin Induces CD34(+) Differentiation in Endothelial Progenitor Cells
por: Boisson-Vidal, Catherine, et al.
Publicado: (2018)

Expression and prognosis of the B7 family in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2021)

Comprehensive Analysis of CRIP1 Expression in Acute Myeloid Leukemia
por: Gao, Yan, et al.
Publicado: (2022)

Near-infrared oxidative phosphorylation inhibitor integrates acute myeloid leukemia–targeted imaging and therapy
por: Zhang, Chi, et al.
Publicado: (2021)

Influence of neonatal gender on cord blood CD34(+) cell amplification and gene expression
por: Zhou, Liping, et al.
Publicado: (2019)

Targeting ERRα promotes cytotoxic effects against acute myeloid leukemia through suppressing mitochondrial oxidative phosphorylation
por: Seo, Wonhyoung, et al.
Publicado: (2022)

Abnormal expression and methylation of PRR34‐AS1 are associated with adverse outcomes in acute myeloid leukemia
por: Nan, Fang‐yu, et al.
Publicado: (2021)

Differentially expressed genes responsible for insensitivity of CD34+ cells to kinase inhibitors in patients with chronic myeloid leukemia
por: Moreira-Nunes, Caroline FA, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nriaphb9r8e0hfjnpoqnnqp4qk